ACE Inhibitors News and Research

RSS
ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACE inhibitors currently are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy.
Two common blood pressure drugs are not tied to increased risk of COVID-19

Two common blood pressure drugs are not tied to increased risk of COVID-19

Patient with hypertension or cardiovascular diseases experienced critical disease progression with COVID-19

Patient with hypertension or cardiovascular diseases experienced critical disease progression with COVID-19

Stopping RAS inhibitors linked to risk of adverse outcomes in patients with chronic kidney disease

Stopping RAS inhibitors linked to risk of adverse outcomes in patients with chronic kidney disease

Could the keto diet help prevent or mitigate severe COVID-19?

Could the keto diet help prevent or mitigate severe COVID-19?

Genetic mutation may accelerate heart function decline in DMD patients

Genetic mutation may accelerate heart function decline in DMD patients

Study finds sex differences among young individuals who suffer a heart attack

Study finds sex differences among young individuals who suffer a heart attack

Chronic illnesses promote active SARS-CoV-2 infection via suppressed mucosal immunity

Chronic illnesses promote active SARS-CoV-2 infection via suppressed mucosal immunity

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

Azithromycin use for treating COVID-19 may increase risk of cardiac events

Azithromycin use for treating COVID-19 may increase risk of cardiac events

Computational models screen for coronaviruses likely to infect humans

Computational models screen for coronaviruses likely to infect humans

Mount Sinai hospitals win top quality achievement awards for stroke and cardiac care

Mount Sinai hospitals win top quality achievement awards for stroke and cardiac care

Common heart drugs are safe for patients hospitalized with COVID-19

Common heart drugs are safe for patients hospitalized with COVID-19

SGLT2 inhibitors can slow CKD progression

SGLT2 inhibitors can slow CKD progression

Antihypertensive drugs are not linked to cancer, shows study

Antihypertensive drugs are not linked to cancer, shows study

Common high blood pressure medications do not increase risk of depression

Common high blood pressure medications do not increase risk of depression

New model predicts which COVID-19 patients are at higher risk for hospitalization

New model predicts which COVID-19 patients are at higher risk for hospitalization

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

Common hypertension drugs do not increase risk of severe, fatal COVID-19 infection

Common hypertension drugs do not increase risk of severe, fatal COVID-19 infection

Novel blood test for heart failure could lead to new diagnostics for COVID-19 patients

Novel blood test for heart failure could lead to new diagnostics for COVID-19 patients

Obesity and metabolic syndrome increase risk for severe influenza, COVID-19

Obesity and metabolic syndrome increase risk for severe influenza, COVID-19